Deepbridge confirms EIS and SEIS product range for 2018/19 tax year
Deepbridge Capital, the tax-efficient investment manager, has today (10th October 2018) confirmed its Enterprise Investment Schemes (EIS) and Seed EIS (SEIS) product range for the 2018/19 tax year.
Deepbridge’s EIS and SEIS products continue the company’s heritage of investing in, and supporting, growth-focused UK innovations. These propositions in 2018/19 are:
- Deepbridge Technology Growth EIS.
- Deepbridge Life Sciences EIS.
- Deepbridge Innovation SEIS.
- Deepbridge Life Sciences SEIS.
Having reviewed the propositions in light of the Patient Capital Review and subsequent changes to Government legislation, Deepbridge confirms it believes these propositions adhere entirely with Government intentions and the ‘spirit of EIS.’
Deepbridge has also confirmed that the Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS will usually deploy funds on a monthly basis with the SEIS propositions usually deploying twice a year.
Deepbridge has also announced that the closing date for receipt of EIS subscriptions to be deployed in the 2018/19 tax year will be Tuesday 26th March 2019.
During the last tax year, Deepbridge invested in a total of 43 innovative technology and life sciences companies, supporting over 400 jobs across those investments.
Deepbridge is keen that advisers and their clients are fully informed and aware of the tax advantages available by investing in EIS/SEIS which include: 30% upfront income tax relief (50% for SEIS); tax-free growth; 100% inheritance tax relief after two years; 100% capital gains tax deferral for EIS (50% capital gains tax mitigation for SEIS) and loss relief.
Ian Warwick, Managing Partner at Deepbridge Capital, commented;
“Supporting growth-focused technology and medical innovation requires considerable experience and understanding of these unique sectors. Our ethos has always been about providing the funding alongside practical support and hands-on management that offers investee companies the best opportunity to survive and thrive – and thereby ultimately maximising the potential return to investors.
“Financial advisers and investors are increasingly utilising Deepbridge EIS and SEIS propositions as they seek to access our team’s experience and expertise of providing high quality growth-focused, and ‘Knowledge Intensive’, opportunities which are at the forefront of how we believe EIS funding should be utilised – supporting job creation, developing export opportunities and delivering economic and health efficiencies.”
For further information please visit www.deepbridgecapital.com